Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 23, Pages 8331-8338
Publisher
Proceedings of the National Academy of Sciences
Online
2014-05-20
DOI
10.1073/pnas.1400352111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacodynamics, Population Dynamics, and the Evolution of Persistence in Staphylococcus aureus
- (2013) Paul J. T. Johnson et al. PLoS Genetics
- “One-Size-Fits-All”? Optimizing Treatment Duration for Bacterial Infections
- (2012) Patricia Geli et al. PLoS One
- Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum
- (2012) Peter Ankomah et al. PLoS Pathogens
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
- (2011) Johan W. Mouton et al. DRUG RESISTANCE UPDATES
- Population biological principles of drug-resistance evolution in infectious diseases
- (2011) Pia Abel zur Wiesch et al. LANCET INFECTIOUS DISEASES
- Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes
- (2011) Iñaki Comas et al. NATURE GENETICS
- The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
- (2011) A. F. Read et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
- (2010) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
- (2010) Robert S. Wallis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Dynamics of Antibiotic Treatment: a Mathematical Model and Hypotheses for Time-Kill and Continuous-Culture Experiments
- (2010) B. R. Levin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- On the Control of Acute Rodent Malaria Infections by Innate Immunity
- (2010) Beth F. Kochin et al. PLoS One
- The problems of antibiotic overuse
- (2010) Vilhjalmur Ari Arason et al. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
- Antibiotic resistance—What’s dosing got to do with it?
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Functional relationship between bacterial cell density and the efficacy of antibiotics
- (2009) K. I. Udekwu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
- (2009) Linda L. Marcusson et al. PLoS Pathogens
- Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients
- (2008) C.R. Hansen et al. Journal of Cystic Fibrosis
- Exploring the role of the immune response in preventing antibiotic resistance
- (2008) Andreas Handel et al. JOURNAL OF THEORETICAL BIOLOGY
- The Impact of Different Antibiotic Regimens on the Emergence of Antimicrobial-Resistant Bacteria
- (2008) Erika M. C. D'Agata et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search